qdel

Quidel Reports Acquisition of Alere Triage Assets

Quidel Reports Acquisition of Alere Triage Assets

Quidel Corp. (NASDAQ: QDEL) announced today that it has reached an agreement to acquire Alere Inc.'s (NYSE: ALR) Triage B-type Natriuretic Peptide assay business and its Triage MeterPro cardiovascular and toxicology assets for $400 million and $..